Acquiring Company
Esteve
Acquired Company
Regis Technologies
Barcelona
ChicagoManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyDescription
ESTEVE has acquired Regis Technologies, enhancing its contract development and manufacturing capacity in the U.S. This acquisition allows ESTEVE to establish a physical presence in the U.S. and expand its offerings for innovative pharmaceutical active ingredients. The move is part of ESTEVE's commitment to improving lives through enhanced CDMO capabilities.
Quick answer
Esteve is acquiring Regis Technologies, announced July 31, 2025. Esteve is based in Barcelona, Catalonia, Spain.
- How much did Esteve pay for Regis Technologies?
- The deal value was not disclosed.
- What does Esteve do?
- Esteve is a global pharmaceutical company headquartered in Barcelona, focused on providing solutions for unmet medical needs.
- Where are Esteve and Regis Technologies based?
- Esteve is based in Barcelona, Catalonia, Spain. Regis Technologies is based in Chicago, Illinois, United States.
- Who are the decision-makers at Esteve?
- Fundz holds 1 contact at Esteve. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
- AbbVie completes acquisition of Capstan Therapeutics (August 19, 2025)
- AbbVie to acquire Capstan Therapeutics (July 15, 2025)
- AbbVie to acquire Capstan Therapeutics for $2.1B, $2.1B (June 30, 2025)
- Rubicon Research acquires Alkem's manufacturing unit (June 24, 2025)
- Bausch Health acquires DURECT for $63M, $63M (September 11, 2025)
Who to call at Esteve, and when
When Esteve changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Esteve raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Esteve, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Esteve. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Esteve makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Regis Technologies?
Regis Technologies was acquired by Esteve, based in Barcelona. The deal was reported on July 31, 2025. Esteve is a global pharmaceutical company headquartered in Barcelona, focused on providing solutions for unmet medical needs. Esteve is privately held and operates in Manufacturing.
When did Esteve acquire Regis Technologies?
Esteve's acquisition of Regis Technologies was reported on July 31, 2025. ESTEVE has acquired Regis Technologies, enhancing its contract development and manufacturing capacity in the U.S. This acquisition allows ESTEVE to establish a physical presence in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Regis Technologies do?
Regis Technologies partners with pharmaceutical and biotechnology companies to streamline drug development processes. Founded in 1956, it offers a variety of services, including cGMP API manufacturing and analytical development. It is privately held, operating in Manufacturing, and is based in Chicago.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.